Last 524.50 GBp
Change Today -5.50 / -1.04%
Volume 1.2M
REX On Other Exchanges
Symbol
Exchange
REX is not on other exchanges.
As of 11:35 AM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Shane Cooke

President, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 7 board members in 2 different organizations across 3 different industries.

See Board Relationships
52$3,164,580
As of Fiscal Year 2013

Background*

Mr. Shane Cooke has been the President at Alkermes Plc since September 16, 2011. Mr. Cooke served as an Executive Vice President of Elan Drug Technologies Inc. since May 2007 and served as its Head of Elan Drug Technologies (EDT). He served as an Executive Vice President and Head of Elan Drug Technologies (EDT) of Elan Corporation, plc from July 2001 to September 15, 2011 and from May 2007 to September 15, 2011. He served as the Chief Financial Officer of Elan Corporation, ...

Read Full Background

Corporate Headquarters*

4 Millbank
London, Greater London SW1P 3XR

United Kingdom

Phone: 44 20 7227 4100
Fax: 44 20 7227 4109

Board Members Memberships*

Director
2005-2011
Former Executive Vice President, Head of Elan Drug Technologies and Executive Director
2012-Present
Director

Education*

Unknown/Other Education
University College Dublin

Other Affiliations*

Annual Compensation*

Salary$579,916
Total Annual Compensation$579,916

Stock Options*

Restricted Stock Awards$372,375
All Other Compensation$172,689
Exercisable Options215,000
Exercisable Options Value$5,524,900
Unexercisable Options410,000
Unexercisable Options Value$8,251,800
Total Value of Options$13,776,700
Total Number of Options625,000

Total Compensation*

Total Annual Cash Compensation$1,502,605
Total Short Term Compensation$579,916
Other Long Term Compensation$545,064
Total Calculated Compensation$3,164,580
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REX:LN 524.50 GBp -5.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REXAM PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.